Capricor Therapeutics ROA 2006-2019 | CAPR

Current and historical return on assets (ROA) values for Capricor Therapeutics (CAPR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Capricor Therapeutics ROA for the three months ending September 30, 2019 was -114.31%.
Capricor Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2019-09-30 $-0.01B $0.01B -121.21%
2019-06-30 $-0.01B $0.01B -129.73%
2019-03-31 $-0.01B $0.01B -127.27%
2018-12-31 $-0.02B $0.01B -120.00%
2018-09-30 $0.00B $0.01B 0.00%
2018-06-30 $0.00B $0.01B 6.56%
2018-03-31 $0.00B $0.02B 13.11%
2017-12-31 $0.00B $0.02B 13.33%
2017-09-30 $-0.02B $0.02B -95.24%
2017-06-30 $-0.02B $0.01B -95.77%
2017-03-31 $-0.02B $0.01B -107.04%
2016-12-31 $-0.02B $0.02B -102.70%
2016-09-30 $-0.02B $0.02B -95.77%
2016-06-30 $-0.02B $0.01B -89.55%
2016-03-31 $-0.01B $0.02B -67.53%
2015-12-31 $-0.01B $0.02B -55.17%
2015-09-30 $-0.01B $0.02B -51.76%
2015-06-30 $-0.01B $0.02B -49.38%
2015-03-31 $-0.01B $0.03B -48.00%
2014-12-31 $-0.01B $0.01B -43.75%
2014-09-30 $-0.01B $0.02B -64.29%
2014-06-30 $-0.01B $0.02B -90.00%
2014-03-31 $-0.01B $0.02B -163.64%
2013-12-31 $-0.01B $0.01B -600.00%
2013-09-30 $-0.01B $0.00B -400.00%
2013-06-30 $-0.00B $0.00B -320.00%
2013-03-31 $-0.00B $0.00B -133.33%
2012-12-31 $-0.00B $0.01B -114.29%
2012-09-30 $-0.00B $0.00B -533.33%
2012-06-30 $-0.00B $0.00B -266.67%
2012-03-31 $-0.01B $0.00B -222.22%
2011-12-31 $-0.01B $0.00B -200.00%
2011-09-30 $-0.00B $0.00B -123.08%
2011-06-30 $-0.01B $0.00B -133.33%
2011-03-31 $-0.01B $0.00B -117.65%
2010-12-31 $-0.01B $0.00B -141.18%
2010-09-30 $-0.01B $0.01B -164.71%
2010-06-30 $-0.01B $0.01B -164.71%
2010-03-31 $-0.01B $0.00B -276.92%
2009-12-31 $-0.01B $0.00B -240.00%
2009-09-30 $-0.01B $0.01B -235.29%
2009-06-30 $-0.01B $0.00B -220.00%
2009-03-31 $-0.01B $0.00B -165.52%
2008-12-31 $-0.01B $0.01B -133.33%
2008-09-30 $-0.01B $0.01B -104.00%
2008-06-30 $-0.02B $0.01B -104.92%
2008-03-31 $-0.01B $0.01B -104.00%
2007-12-31 $-0.01B $0.02B -122.22%
2007-09-30 $-0.01B $0.02B -210.53%
2007-06-30 $-0.01B $0.00B inf%
2007-03-31 $-0.00B $0.00B inf%
2006-12-31 $-0.00B $0.00B inf%
2006-09-30 $-0.00B $0.00B inf%
2006-06-30 $0.00B $0.00B nan%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.008B $0.002B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $159.545B 22.04
Abbott Laboratories (ABT) United States $157.393B 28.71
Stryker (SYK) United States $79.374B 26.69
Boston Scientific (BSX) United States $61.719B 29.13
Baxter (BAX) United States $45.812B 27.78
Essilor Luxottica (ESLOY) France $35.128B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.725B 19.27
Lonza Group Ag (LZAGY) Switzerland $28.134B 0.00
Coloplast (CLPBY) Denmark $27.648B 42.67
Terumo (TRUMY) Japan $26.986B 0.00
ResMed (RMD) United States $23.088B 42.59
Smith & Nephew SNATS (SNN) United Kingdom $21.557B 0.00
Sunny Optical Technology (SNPTF) China $20.017B 0.00
Insulet (PODD) United States $11.669B 555.18
Bio-Rad Laboratories (BIO) United States $11.282B 54.15
Canopy Growth (CGC) Canada $8.676B 0.00
Perrigo (PRGO) Ireland $8.033B 14.98
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Hill-Rom Holdings (HRC) United States $7.750B 22.78
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.770B 38.99
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.065B 32.01
ICU Medical (ICUI) United States $3.960B 25.81
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
Neogen (NEOG) United States $3.757B 62.53
GW Pharmaceuticals (GWPH) United Kingdom $3.675B 0.00
Agios Pharmaceuticals (AGIO) United States $3.113B 0.00
Quidel (QDEL) United States $3.020B 28.66
National Vision Holdings (EYE) United States $2.597B 58.63
Aurora Cannabis (ACB) Canada $2.321B 0.00
Cardiovascular Systems (CSII) United States $1.887B 0.00
AtriCure (ATRC) United States $1.513B 0.00
InMode (INMD) Israel $1.440B 0.00
TG Therapeutics (TGTX) United States $1.364B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.206B 24.09
NanoString Technologies (NSTG) United States $1.101B 0.00
Phibro Animal Health (PAHC) United States $1.043B 19.54
PetIQ (PETQ) United States $0.869B 21.20
Eagle Pharmaceuticals (EGRX) United States $0.806B 30.87
Lantheus Holdings (LNTH) United States $0.742B 18.54
LeMaitre Vascular (LMAT) United States $0.737B 41.43
Omeros (OMER) United States $0.678B 0.00
Quanterix (QTRX) United States $0.675B 0.00
Cerus (CERS) United States $0.571B 0.00
Surmodics (SRDX) United States $0.560B 58.06
MacroGenics (MGNX) United States $0.551B 0.00
Organigram Holdings (OGI) Canada $0.509B 0.00
OraSure Technologies (OSUR) United States $0.507B 30.44
HEXO (HEXO) $0.441B 0.00
Meridian Bioscience (VIVO) United States $0.424B 14.54
Utah Medical Products (UTMD) United States $0.392B 28.37
Zynex (ZYXI) United States $0.350B 39.59
Owens & Minor (OMI) United States $0.346B 12.81
BioLife Solutions (BLFS) United States $0.332B 135.08
Neptune Wellness Solutions (NEPT) Canada $0.285B 0.00
Bovie Medical (APYX) United States $0.277B 0.00
Female Health (VERU) United States $0.273B 0.00
Vapotherm (VAPO) United States $0.259B 0.00
United Health Products (UEEC) United States $0.233B 0.00
Repro-Med Systems (KRMD) United States $0.225B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.04
Green Organic Dutchman Holdings (TGODF) Canada $0.178B 0.00
Liberty Health Sciences (LHSIF) Canada $0.177B 0.00
Rockwell Medical (RMTI) United States $0.166B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.134B 9.43
Chimerix (CMRX) United States $0.125B 0.00
MTech Acquisition (KERN) United States $0.097B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.095B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
United-Guardian (UG) United States $0.089B 22.57
MRI Interventions (MRIC) United States $0.086B 0.00
Nephros (NEPH) United States $0.074B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) $0.051B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.025B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Senestech (SNES) United States $0.016B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00